Senseonics Holdings (SENS) Shares Outstanding (Weighted Average) (2014 - 2026)
Senseonics Holdings (SENS) reported Shares Outstanding (Weighted Average) of $45.8 million for Q1 2026, up 27.48% year-over-year from $35.9 million in Q1 2025, and up 9.81% on a QoQ basis from $41.7 million in Q4 2025.
Senseonics Holdings (SENS) has 13 years of Shares Outstanding (Weighted Average) data on file, last reported at $45.8 million in Q1 2026.
- Quarterly Shares Outstanding (Weighted Average) rose 27.48% year-over-year to $45.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $45.8 million (up 27.48% YoY) and the FY2025 annual result came in at $41.7 million, up 32.53% from the prior year.
- Shares Outstanding (Weighted Average) climbed to $45.8 million in Q1 2026 per SENS's latest filing, from $41.7 million in the prior quarter.
- Across five years, Shares Outstanding (Weighted Average) topped out at $766.4 million in Q2 2025 and bottomed at $30.9 million in Q3 2024.
- The 5-year median for Shares Outstanding (Weighted Average) is $464.2 million (2022), against an average of $368.5 million.
- The widest annual swing landed in 2024, when Shares Outstanding (Weighted Average) plunged 94.46%; it then jumped 45.63% in 2025.
- Tracing SENS's Shares Outstanding (Weighted Average) over 5 years: stood at $468.0 million in 2022, then grew by 21.37% to $568.0 million in 2023, then sank by 94.46% to $31.5 million in 2024, then soared by 32.53% to $41.7 million in 2025, then advanced by 9.81% to $45.8 million in 2026.
- Per Business Quant, the three latest SENS Shares Outstanding (Weighted Average) figures stand at $45.8 million (Q1 2026), $41.7 million (Q4 2025), and $45.0 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares (Weighted Avg.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 1.74 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 382.90 Mn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 1.28 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 1.48 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 579.20 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 385.10 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 456.00 Mn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 98.20 Mn |
| 10 | Senseonics Holdings | 316.18 Mn | 251.85 Mn | 6.94 Mn | 45.82 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 45.82 Mn |
| Dec 31, 2025 | 41.73 Mn |
| Sep 30, 2025 | 44.95 Mn |
| Jun 30, 2025 | 766.38 Mn |
| Mar 31, 2025 | 35.94 Mn |
| Dec 31, 2024 | 31.49 Mn |
| Sep 30, 2024 | 30.87 Mn |
| Jun 30, 2024 | 615.59 Mn |
| Mar 31, 2024 | 614.59 Mn |
| Dec 31, 2023 | 567.97 Mn |
| Sep 30, 2023 | 552.70 Mn |
| Jun 30, 2023 | 567.13 Mn |
| Mar 31, 2023 | 497.47 Mn |
| Dec 31, 2022 | 467.95 Mn |
| Sep 30, 2022 | 464.24 Mn |
| Jun 30, 2022 | 464.13 Mn |
| Mar 31, 2022 | 455.94 Mn |
| Dec 31, 2021 | 422.32 Mn |
| Sep 30, 2021 | 414.13 Mn |
| Jun 30, 2021 | 398.24 Mn |
| Mar 31, 2021 | 364.27 Mn |
| Dec 31, 2020 | 227.91 Mn |
| Sep 30, 2020 | 220.25 Mn |
| Jun 30, 2020 | 220.31 Mn |
| Mar 31, 2020 | 203.75 Mn |
| Dec 31, 2019 | 188.75 Mn |
| Sep 30, 2019 | 183.80 Mn |
| Jun 30, 2019 | 177.01 Mn |
| Mar 31, 2019 | 176.95 Mn |
| Dec 31, 2018 | 157.43 Mn |
| Sep 30, 2018 | 150.87 Mn |
| Jun 30, 2018 | 137.92 Mn |
| Mar 31, 2018 | 137.07 Mn |
| Dec 31, 2017 | 115.98 Mn |
| Sep 30, 2017 | 108.96 Mn |
| Jun 30, 2017 | 103.69 Mn |
| Mar 31, 2017 | 93.91 Mn |
| Dec 31, 2016 | 89.24 Mn |
| Sep 30, 2016 | 87.84 Mn |
| Jun 30, 2016 | 92.74 Mn |
| Mar 31, 2016 | 77.32 Mn |
| Dec 31, 2015 | 7.00 Mn |
| Sep 30, 2015 | 1.94 Mn |
| Jun 30, 2015 | 1.94 Mn |
| Mar 31, 2015 | 1.93 Mn |
| Dec 31, 2014 | 1.91 Mn |
| Sep 30, 2014 | 120.00 Mn |
| Jun 30, 2014 | 2.00 Mn |